score,metric,date,value,year,sentence,number
0.778269350528717,cash on balance sheet,"december 31, 2020",$2.9 billion,2020,"as of december 31, 2020, our total balance of cash, cash equivalents and marketable securities was $2.9 billion, of which approximately $421.0 million was held outside the u.s",2900000000.0
0.6365014314651489,marketable securities,"the year ended december 31, 2019",$1.5 billion,2019,"during the year ended december 31, 2019, cash used in investing activities was $284.1 million, primarily consisting of purchases of available-for-sale securities of $1.5 billion, and purchases of property and",1500000000.0
0.6289984583854675,marketable securities,"the year ended december 31, 2020",$773.0 million,2020,"during the year ended december 31, 2020, cash used in investing activities was $608.8 million, primarily consisting of purchases of available-for-sale securities of $2.7 billion, $227.4 million for the acquisition of big switch and awake security, and purchases of property, equipment and intangible assets of 15.4 million, partially offset by proceeds of $1.5 billion from maturities of marketable securities, proceeds from the sale of marketable securities of $773.0 million and proceeds from the sale of one of our investments in privately-held companies of $3.4 million.",773000000.0
0.5814505815505981,marketable securities,2019,$2.7 billion,2019,"as of december 31, 2020 and 2019, we had cash, cash equivalents and available-for-sale marketable securities totaling $2.9 billion and $2.7 billion, respectively",2700000000.0
0.5184860229492188,marketable securities,"the third quarter of the year ended december 31, 2020",$9.4 million,2020,"this was partially offset by a realized gain of $9.4 million on the sale of marketable securities in the third quarter of the year ended december 31, 2020.",9400000.0
0.3663769662380218,r&d value,"the year ended december 31, 2019",$20.3 million,2019,"research and development expenses increased $20.3 million, or 4.6%, for the year ended december 31, 2019 compared to 2018",20300000.0
0.3529364764690399,r&d value,"the year ended december 31, 2020",$23.8 million,2020,"research and development expenses increased $23.8 million, or 5.2%, for the year ended december 31, 2020 compared to 2019",23800000.0
0.2048605382442474,total number of customers,"the year ended december 31, 2019",two,2019,"for the year ended december 31, 2019, there were two customers who represented 23% and 17% of our total revenue, respectively.",2.0
0.1089553460478782,marketable securities,2019,$19.2 million,2019,"the favorable change in other income, net, during the year ended december 31, 2019 as compared to 2018 was driven by a $19.5 million increase in interest income, as we continued to generate cash and expand our marketable securities portfolios, and a $19.2 million favorable change on our investments in privately-held companies resulting from the gain on certain investments of $5.4 million in 2019, compared to a net loss of $13.8 million on these investments during 2018",19200000.0
